Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.

Spinello I, Saulle E, Quaranta MT, Pasquini L, Pelosi E, Castelli G, Ottone T, Voso MT, Testa U, Labbaye C.

Haematologica. 2019 May;104(5):973-985. doi: 10.3324/haematol.2018.199661. Epub 2018 Nov 22.

2.

The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.

Fabiani E, Falconi G, Noguera NI, Saulle E, Cicconi L, Divona M, Banella C, Picardi A, Cerio AM, Boe L, Sanchez M, Pelosi E, Testa U, Lo-Coco F, Voso MT.

Oncotarget. 2017 Sep 20;8(48):84074-84085. doi: 10.18632/oncotarget.21101. eCollection 2017 Oct 13.

3.

Endothelial progenitor cells in hematologic malignancies.

Testa U, Saulle E, Castelli G, Pelosi E.

Stem Cell Investig. 2016 Jul 1;3:26. doi: 10.21037/sci.2016.06.07. eCollection 2016. Review.

4.

PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response.

Saulle E, Petronelli A, Pelosi E, Coppotelli E, Pasquini L, Ilari R, Lo-Coco F, Testa U.

J Hematol Oncol. 2016 Apr 7;9:33. doi: 10.1186/s13045-016-0262-5.

5.

Differential hypoxic regulation of the microRNA-146a/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy.

Spinello I, Quaranta MT, Paolillo R, Pelosi E, Cerio AM, Saulle E, Lo Coco F, Testa U, Labbaye C.

Haematologica. 2015 Sep;100(9):1160-71. doi: 10.3324/haematol.2014.120295. Epub 2015 Jun 4.

6.

Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines.

Calzolari A, Saulle E, De Angelis ML, Pasquini L, Boe A, Pelacchi F, Ricci-Vitiani L, Baiocchi M, Testa U.

PLoS One. 2014 Apr 16;9(4):e94438. doi: 10.1371/journal.pone.0094438. eCollection 2014.

7.

Autocrine role of angiopoietins during megakaryocytic differentiation.

Saulle E, Guerriero R, Petronelli A, Coppotelli E, Gabbianelli M, Morsilli O, Spinello I, Pelosi E, Castelli G, Testa U, Coppola S.

PLoS One. 2012;7(7):e39796. doi: 10.1371/journal.pone.0039796. Epub 2012 Jul 6.

8.

A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells.

Petrucci E, Pasquini L, Bernabei M, Saulle E, Biffoni M, Accarpio F, Sibio S, Di Giorgio A, Di Donato V, Casorelli A, Benedetti-Panici P, Testa U.

PLoS One. 2012;7(4):e35073. doi: 10.1371/journal.pone.0035073. Epub 2012 Apr 25.

9.

CDDO-Im is a stimulator of megakaryocytic differentiation.

Petronelli A, Pelosi E, Santoro S, Saulle E, Cerio AM, Mariani G, Labbaye C, Testa U.

Leuk Res. 2011 Apr;35(4):534-44. doi: 10.1016/j.leukres.2010.09.013. Epub 2010 Oct 29.

PMID:
21035854
10.

Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex.

Gabbianelli M, Testa U, Morsilli O, Pelosi E, Saulle E, Petrucci E, Castelli G, Giovinazzi S, Mariani G, Fiori ME, Bonanno G, Massa A, Croce CM, Fontana L, Peschle C.

Haematologica. 2010 Aug;95(8):1253-60. doi: 10.3324/haematol.2009.018259. Epub 2010 Mar 19.

11.

Primary ovarian cancer cells are sensitive to the proaptotic effects of proteasome inhibitors.

Pasquini L, Petronelli A, Petrucci E, Saulle E, Mariani G, Scambia G, Benedetti-Panici P, Greggi S, Cognetti F, Testa U.

Int J Oncol. 2010 Mar;36(3):707-13.

PMID:
20126991
12.

High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide.

Petronelli A, Saulle E, Pasquini L, Petrucci E, Mariani G, Biffoni M, Ferretti G, Scambia G, Benedetti-Panici P, Greggi S, Cognetti F, Russo MA, Sporn M, Testa U.

Cancer Lett. 2009 Sep 18;282(2):214-28. doi: 10.1016/j.canlet.2009.03.018. Epub 2009 Apr 11.

PMID:
19364626
13.

Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.

Saulle E, Riccioni R, Coppola S, Parolini I, Diverio D, Riti V, Mariani G, Laufer S, Sargiacomo M, Testa U.

Br J Haematol. 2009 May;145(3):399-411. doi: 10.1111/j.1365-2141.2009.07627.x. Epub 2009 Feb 24.

PMID:
19245429
14.

Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.

Riccioni R, Diverio D, Mariani G, Buffolino S, Riti V, Saulle E, Petrucci E, Cedrone M, Lo-Coco F, Foà R, Peschle C, Testa U.

Stem Cells. 2007 Aug;25(8):1862-71. Epub 2007 Apr 19.

15.

A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.

Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R, Biffoni M, Ferretti G, Benedetti-Panici P, Cognetti F, Scambia G, Humphreys R, Peschle C, Testa U.

Gynecol Oncol. 2007 May;105(2):481-92. Epub 2007 Feb 9.

PMID:
17292950
16.

Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.

Saulle E, Petronelli A, Pasquini L, Petrucci E, Mariani G, Biffoni M, Ferretti G, Scambia G, Benedetti-Panici P, Cognetti F, Humphreys R, Peschle C, Testa U.

Apoptosis. 2007 Apr;12(4):635-55.

PMID:
17252198
17.

In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.

Saulle E, Riccioni R, Pelosi E, Stafness M, Mariani G, De Tuglie G, Peschle C, Testa U.

Blood Cells Mol Dis. 2006 Jan-Feb;36(1):59-76. Epub 2005 Dec 15.

PMID:
16360329
18.

TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.

Riccioni R, Pasquini L, Mariani G, Saulle E, Rossini A, Diverio D, Pelosi E, Vitale A, Chierichini A, Cedrone M, Foà R, Lo Coco F, Peschle C, Testa U.

Haematologica. 2005 May;90(5):612-24.

19.

Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease.

Saulle E, Gubellini P, Picconi B, Centonze D, Tropepi D, Pisani A, Morari M, Marti M, Rossi L, Papa M, Bernardi G, Calabresi P.

Mol Cell Neurosci. 2004 Jan;25(1):9-20.

PMID:
14962736
20.

Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia.

Costa C, Leone G, Saulle E, Pisani F, Bernardi G, Calabresi P.

Stroke. 2004 Feb;35(2):596-600. Epub 2004 Jan 15.

PMID:
14726544
21.

Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity.

Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, Pavón N, Pisani A, Bernardi G, Moratalla R, Calabresi P.

J Neurosci. 2003 Sep 17;23(24):8506-12.

22.

Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study.

Calabresi P, Marti M, Picconi B, Saulle E, Costa C, Centonze D, Pisani F, Bernardi G.

Exp Neurol. 2003 Aug;182(2):461-9.

PMID:
12895457
23.

Corticostriatal LTP requires combined mGluR1 and mGluR5 activation.

Gubellini P, Saulle E, Centonze D, Costa C, Tropepi D, Bernardi G, Conquet F, Calabresi P.

Neuropharmacology. 2003 Jan;44(1):8-16.

PMID:
12559117
24.

C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.

Riccioni R, Saulle E, Militi S, Sposi NM, Gualtiero M, Mauro N, Mancini M, Diverio D, Lo Coco F, Peschle C, Testa U.

Leukemia. 2003 Jan;17(1):98-113.

PMID:
12529666
25.

Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors.

Saulle E, Centonze D, Martín AB, Moratalla R, Bernardi G, Calabresi P.

Stroke. 2002 Dec;33(12):2978-84.

PMID:
12468800
26.

HbF reactivation in sibling BFU-E colonies: synergistic interaction of kit ligand with low-dose dexamethasone.

Gabbianelli M, Testa U, Massa A, Morsilli O, Saulle E, Sposi NM, Petrucci E, Mariani G, Peschle C.

Blood. 2003 Apr 1;101(7):2826-32. Epub 2002 Nov 7.

27.

Tissue plasminogen activator is required for corticostriatal long-term potentiation.

Centonze D, Napolitano M, Saulle E, Gubellini P, Picconi B, Martorana A, Pisani A, Gulino A, Bernardi G, Calabresi P.

Eur J Neurosci. 2002 Aug;16(4):713-21.

PMID:
12270047
28.

Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression.

Daw MI, Bortolotto ZA, Saulle E, Zaman S, Collingridge GL, Isaac JT.

Nat Neurosci. 2002 Sep;5(9):835-6.

PMID:
12161757
29.

Receptor and post-receptor mechanisms of ischemic long-term potentiation in the striatum.

Centonze D, Saulle E, Bernardi G, Calabresi P.

Funct Neurol. 2001;16(4 Suppl):149-52. Review. No abstract available.

PMID:
11996510
30.

Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation.

Centonze D, Saulle E, Pisani A, Bonsi P, Tropepi D, Bernardi G, Calabresi P.

Neuroreport. 2002 Jan 21;13(1):115-8.

PMID:
11924871
31.

Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability.

Calabresi P, Saulle E, Centonze D, Pisani A, Marfia GA, Bernardi G.

Brain. 2002 Apr;125(Pt 4):844-60.

PMID:
11912117
32.

Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum.

Calabresi P, Saulle E, Marfia GA, Centonze D, Mulloy R, Picconi B, Hipskind RA, Conquet F, Bernardi G.

Mol Pharmacol. 2001 Oct;60(4):808-15.

PMID:
11562444
33.

Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia.

Centonze D, Saulle E, Pisani A, Bernardi G, Calabresi P.

Brain. 2001 Sep;124(Pt 9):1855-65.

PMID:
11522587
34.

An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease.

Centonze D, Gubellini P, Picconi B, Saulle E, Tolu M, Bonsi P, Giacomini P, Calabresi P.

Neurol Sci. 2001 Feb;22(1):61-2.

PMID:
11487202
35.

A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication.

Calabresi P, Ammassari-Teule M, Gubellini P, Sancesario G, Morello M, Centonze D, Marfia GA, Saulle E, Passino E, Picconi B, Bernardi G.

Neurobiol Dis. 2001 Jun;8(3):419-32.

PMID:
11442351
36.

Selective involvement of mGlu1 receptors in corticostriatal LTD.

Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P.

Neuropharmacology. 2001 Jun;40(7):839-46.

PMID:
11378154
37.

Mechanisms of differential transferrin receptor expression in normal hematopoiesis.

Sposi NM, Cianetti L, Tritarelli E, Pelosi E, Militi S, Barberi T, Gabbianelli M, Saulle E, Kühn L, Peschle C, Testa U.

Eur J Biochem. 2000 Dec;267(23):6762-74.

38.

Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects.

Calabresi P, Stefani A, Marfia GA, Hainsworth AH, Centonze D, Saulle E, Spadoni F, Leach MJ, Giacomini P, Bernardi G.

Exp Neurol. 2000 Mar;162(1):171-9.

PMID:
10716897
39.

Is pharmacological neuroprotection dependent on reduced glutamate release?

Calabresi P, Picconi B, Saulle E, Centonze D, Hainsworth AH, Bernardi G.

Stroke. 2000 Mar;31(3):766-72; discussion 773.

PMID:
10700517
40.

Rapid communication: nucleotide sequence of chamois, alpine ibex, and red deer tRNA(Lys) and ATPase8 mitochondrial genes.

Saulle E, Di Pasquale S, Tartaglia M.

J Anim Sci. 1999 Dec;77(12):3398-9. No abstract available.

PMID:
10641890
41.

Fibroblast growth factor receptor mutational screening in newborns affected by metopic synostosis.

Tartaglia M, Bordoni V, Velardi F, Basile RT, Saulle E, Tenconi R, Di Rocco C, Battaglia PA.

Childs Nerv Syst. 1999 Aug;15(8):389-93; discussion 393-4.

PMID:
10447608
42.

Polymorphism at position 882 of the fibroblast growth factor receptor 3 (FGFR3) gene detected by SSCP analysis.

Tartaglia M, Saulle E, Bordoni V, Battaglia PA.

Mol Cell Probes. 1998 Oct;12(5):335-7. No abstract available.

PMID:
9778460
43.

Rapid communication: nucleotide sequence of porcine and ovine tRNA(Lys) and ATPase8 mitochondrial genes.

Tartaglia M, Saulle E.

J Anim Sci. 1998 Aug;76(8):2207-8. No abstract available.

PMID:
9734874
44.

Detection of bovine mitochondrial DNA in ruminant feeds: a molecular approach to test for the presence of bovine-derived materials.

Tartaglia M, Saulle E, Pestalozza S, Morelli L, Antonucci G, Battaglia PA.

J Food Prot. 1998 May;61(5):513-8.

PMID:
9709219

Supplemental Content

Loading ...
Support Center